Three types of population screening programs are in operation.
Cervical cancer screening programs are switching from Pap screening to high-risk HPV testing.
Cervical cancer screening programs are switching from cytology-based screening to high-risk (hr) HPV testing.
Screening programs are based on the Mantoux tuberculin skin reaction test, which is usually performed by nurses.
As a result of the NLST and other studies, imaging-based lung cancer screening programs are now being implemented.
As primary HPV screening programs are rolled out, methods are needed for routine quality assurance of HPV laboratory analyzes.
At the same time, proven interventions, like prenatal care and screening programs, are underused or difficult to access because of the lack of competitive reimbursement.
We propose that this factor be recognized, in conjunction with evidence of clinical utility based on chronological age, as genomic screening programs are developed.
Social understanding of age is an underappreciated factor at play in how genomic screening programs are designed and offered, and in motivations to participate.
In contrast to the recommendations of the Joint Committee on Infant Hearing, neonatal hearing screening programs are still not universally available.
Community fecal immunochemical testing (FIT) screening programs are important for detecting early disease and can be effective when promoted by primary care physicians.
